Insmed (INSM) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
Revenue Growth %: +253.1%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +253.1%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($0.50), $0.03 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- BlackRock’s Rosenberg says inflation data key after jobs beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
